Reference number : 236-2018-2019-Q2-00284, amendment number : , agreement type : G, recipient legal name : Klonisch, Thomas, recipient country : CA, recipient province : MB, recipient city : Winnipeg, recipient postal code : R3T 2N2, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 60000.0, agreement start date : 2018-09-01, agreement end date : 2021-08-31, description english : Highly selective targeting of ABL kinase in patient-derived brain tumor initiating cells., description french : Highly selective targeting of ABL kinase in patient-derived brain tumor initiating cells., expected results english : nan, expected results french : nan, additional information english : nan, additional information french : nan, owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada